Composite Fibrin/Carbon Microfiber Implants for Bridging Spinal Cord Injury: A Translational Approach in Pigs
Alexandra Alves-Sampaio1, Patricia Del-Cerro1, Jorge E Collazos-Castro1
1Neural Repair and Biomaterials Laboratory, Hospital Nacional de Parapléjicos (SESCAM), Finca La Peraleda S-N, 45071 Toledo, Spain.
International Journal of Molecular Sciences
|July 14, 2023
Summary
Researchers tested biomaterial implants in a pig spinal cord injury (SCI) model. While implants aided axonal growth, they increased lesion size and failed to prevent scarring, indicating a need for improved biomaterials and pharmaceuticals for neural repair.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Regenerative Medicine
Background:
- Spinal cord injury (SCI) poses significant challenges for neural repair.
- Biomaterials offer potential for enhancing neural regeneration after SCI.
- Large animal models are crucial for translating SCI therapies to clinical use.
Purpose of the Study:
- To evaluate the efficacy of fibrin gel-based biomaterial implants containing biofunctionalized carbon microfibers (MFs) in a porcine SCI model.
- To investigate the impact of myelotomy and lesion debridement on neural repair.
- To assess the potential of MFs/fibrin gel for bridging spinal cord cavities and promoting axonal regeneration.
Main Methods:
- Development of a porcine contusion/compression SCI model using an automated device.
- Performance of dorsal myelotomy and lesion debridement one day post-injury.
- Implantation of fibrin gel with biofunctionalized carbon microfibers into the lesion site.
- Histological and functional assessments of neural regeneration and tissue response.
Main Results:
- Myelotomy and debridement did not worsen neural damage but showed limited benefit for neural regrowth.
- The MFs/fibrin gel implant promoted axonal sprouting, elongation, and alignment within the lesion.
- The implant increased lesion volume and did not prevent fibrosis, hindering functional neural regeneration.
Conclusions:
- Myelotomy and lesion debridement are viable for implanting MF-based scaffolds in SCI.
- Current MF-based implants require significant refinement.
- Future strategies must incorporate pharmaceuticals to mitigate scarring and enhance functional neural recovery after SCI.
Keywords:
biomaterialcompressionconducting polymercontusionmicrofibermyelotomypigporcineregenerationspinal cord injury

